PHAT
Price
$9.63
Change
+$0.58 (+6.41%)
Updated
Jul 25 closing price
Capitalization
672.31M
11 days until earnings call
URGN
Price
$18.95
Change
+$0.95 (+5.28%)
Updated
Jul 25 closing price
Capitalization
875.52M
23 days until earnings call
Interact to see
Advertisement

PHAT vs URGN

Header iconPHAT vs URGN Comparison
Open Charts PHAT vs URGNBanner chart's image
Phathom Pharmaceuticals
Price$9.63
Change+$0.58 (+6.41%)
Volume$1.67M
Capitalization672.31M
UroGen Pharma
Price$18.95
Change+$0.95 (+5.28%)
Volume$1.31M
Capitalization875.52M
PHAT vs URGN Comparison Chart in %
Loading...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHAT vs. URGN commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHAT is a StrongBuy and URGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (PHAT: $9.63 vs. URGN: $18.95)
Brand notoriety: PHAT and URGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHAT: 61% vs. URGN: 36%
Market capitalization -- PHAT: $672.31M vs. URGN: $875.52M
PHAT [@Biotechnology] is valued at $672.31M. URGN’s [@Biotechnology] market capitalization is $875.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHAT’s FA Score shows that 0 FA rating(s) are green whileURGN’s FA Score has 0 green FA rating(s).

  • PHAT’s FA Score: 0 green, 5 red.
  • URGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both PHAT and URGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHAT’s TA Score shows that 3 TA indicator(s) are bullish while URGN’s TA Score has 5 bullish TA indicator(s).

  • PHAT’s TA Score: 3 bullish, 4 bearish.
  • URGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, URGN is a better buy in the short-term than PHAT.

Price Growth

PHAT (@Biotechnology) experienced а +21.13% price change this week, while URGN (@Biotechnology) price change was +24.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

PHAT is expected to report earnings on Aug 07, 2025.

URGN is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
URGN($876M) has a higher market cap than PHAT($672M). URGN YTD gains are higher at: 77.934 vs. PHAT (18.596). URGN has higher annual earnings (EBITDA): -119.79M vs. PHAT (-272.12M). PHAT has more cash in the bank: 212M vs. URGN (196M). URGN has less debt than PHAT: URGN (125M) vs PHAT (204M). URGN has higher revenues than PHAT: URGN (91.9M) vs PHAT (81.9M).
PHATURGNPHAT / URGN
Capitalization672M876M77%
EBITDA-272.12M-119.79M227%
Gain YTD18.59677.93424%
P/E RatioN/AN/A-
Revenue81.9M91.9M89%
Total Cash212M196M108%
Total Debt204M125M163%
FUNDAMENTALS RATINGS
URGN: Fundamental Ratings
URGN
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
29

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PHATURGN
RSI
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 26 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DCCAX29.000.19
+0.66%
Macquarie Small Cap Core A
GGEYX28.960.12
+0.42%
GuideStone Funds Growth Equity Instl
JRSTX12.350.04
+0.32%
JH Adaptive Risk Mgd U.S. Eq T
SREQX13.32-0.01
-0.08%
PGIM Select Real Estate R6
BRZKX13.08-0.02
-0.15%
BlackRock Sus Adg Intl Eq K

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with RGNX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
+6.41%
RGNX - PHAT
36%
Loosely correlated
-1.86%
ACIU - PHAT
36%
Loosely correlated
N/A
URGN - PHAT
35%
Loosely correlated
+5.28%
PDSB - PHAT
34%
Loosely correlated
-2.48%
SYRE - PHAT
33%
Poorly correlated
+1.08%
More

URGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, URGN has been loosely correlated with AIM. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if URGN jumps, then AIM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To URGN
1D Price
Change %
URGN100%
+5.28%
AIM - URGN
39%
Loosely correlated
-0.18%
ETNB - URGN
38%
Loosely correlated
-3.91%
ATXS - URGN
36%
Loosely correlated
+1.37%
SCPH - URGN
36%
Loosely correlated
-4.11%
PHAT - URGN
35%
Loosely correlated
+6.41%
More